AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Recruitingn/aAges 18 Years - anyAllThe University of Texas at Arlington
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes. Specific aims include: Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction. Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Cases, Aim 1 1. 18 or older 2. willing to participate under the conditions described in the informed consent form (ICF) 3. eligible to sign the ICF 4. established diagnosis of PAD confirmed by a physician 5. able to comply with the study requirements * Cases, Aim 2 1\) completed Aim 1 * Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease Exclusion Criteria: * Cases, Aim 1 1. Ankle-Brachial Index \>0.9 or \<0.4 2. isolated disease in aorta/iliac vessels 3. unstable angina or myocardial infarction in past 12 months 4. orthopedic or other physical limitations which would prevent data collection 5. contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator * Cases, Aim 2 1. unstable angina or myocardial infarction in past 12 months 2. orthopedic or other physical limitations which would prevent data collection 3. contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator). * Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP \>150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator).
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
University of Texas at Arlington
Arlington, United States
University of Texas Arlington
Arlington, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy